logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Otter, James Anthony
    Born in November 1957
    Individual (10 offsprings)
    Officer
    icon of calendar 2017-03-22 ~ now
    OF - Director → CIF 0
  • 2
    Janeczek, Agnieszka Aleksandra, Dr
    Born in April 1987
    Individual (1 offspring)
    Officer
    icon of calendar 2022-09-01 ~ now
    OF - Director → CIF 0
  • 3
    Ferrara, Lisa Anne
    Born in November 1963
    Individual (1 offspring)
    Officer
    icon of calendar 2024-08-15 ~ now
    OF - Director → CIF 0
  • 4
    Oreffo, Richard, Prof
    Born in September 1961
    Individual (1 offspring)
    Officer
    icon of calendar 2017-03-22 ~ now
    OF - Director → CIF 0
Ceased 7
  • 1
    Jonathan Dawson
    Born in March 1981
    Individual (1 offspring)
    Person with significant control
    icon of calendar 2017-03-22 ~ 2017-10-31
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Otter James
    Born in November 1957
    Individual (10 offsprings)
    Person with significant control
    icon of calendar 2017-03-22 ~ 2017-10-20
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    Prof Richard Oreffo
    Born in September 1961
    Individual (1 offspring)
    Person with significant control
    icon of calendar 2017-03-22 ~ 2017-10-31
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Smith, Peter John Shand, Professor
    Academic born in June 1954
    Individual
    Officer
    icon of calendar 2017-12-19 ~ 2019-04-17
    OF - Director → CIF 0
  • 5
    Harris, Michael
    Ceo born in May 1970
    Individual
    Officer
    icon of calendar 2023-06-26 ~ 2025-03-07
    OF - Director → CIF 0
  • 6
    Sinclair, Simon, Dr
    Director born in May 1972
    Individual (2 offsprings)
    Officer
    icon of calendar 2019-04-17 ~ 2024-08-15
    OF - Director → CIF 0
  • 7
    icon of addressBuilding 37 Finance Department, University Of Southampton, Highfield, Southampton, Hampshire, England
    Active Corporate (5 parents, 1 offspring)
    Person with significant control
    2017-10-31 ~ 2023-06-26
    PE - Has significant influence or control → CIF 0
parent relation
Company in focus

RENOVOS BIOLOGICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
62024-04-01 ~ 2025-03-31
62023-04-01 ~ 2024-03-31
Intangible Assets
5,668 GBP2025-03-31
7,085 GBP2024-03-31
Property, Plant & Equipment
47,934 GBP2025-03-31
1,885 GBP2024-03-31
Fixed Assets
53,602 GBP2025-03-31
8,970 GBP2024-03-31
Debtors
Current
147,234 GBP2025-03-31
39,021 GBP2024-03-31
Cash at bank and in hand
152,119 GBP2025-03-31
646,676 GBP2024-03-31
Current Assets
299,353 GBP2025-03-31
685,697 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-50,074 GBP2025-03-31
Net Current Assets/Liabilities
249,279 GBP2025-03-31
670,085 GBP2024-03-31
Net Assets/Liabilities
302,881 GBP2025-03-31
679,055 GBP2024-03-31
Equity
Called up share capital
37 GBP2025-03-31
37 GBP2024-03-31
Share premium
1,492,918 GBP2025-03-31
1,492,918 GBP2024-03-31
Retained earnings (accumulated losses)
-1,190,074 GBP2025-03-31
-813,900 GBP2024-03-31
Equity
302,881 GBP2025-03-31
679,055 GBP2024-03-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
202024-04-01 ~ 2025-03-31
Office equipment
202024-04-01 ~ 2025-03-31
Computers
202024-04-01 ~ 2025-03-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
14,170 GBP2025-03-31
14,170 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
8,502 GBP2025-03-31
7,085 GBP2024-03-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
5,668 GBP2025-03-31
7,085 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
107,882 GBP2025-03-31
53,655 GBP2024-03-31
Computers
2,786 GBP2025-03-31
2,786 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
111,876 GBP2025-03-31
56,441 GBP2024-03-31
Office equipment
1,208 GBP2025-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
53,655 GBP2024-03-31
Computers
901 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
54,556 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
8,885 GBP2024-04-01 ~ 2025-03-31
Office equipment, Owned/Freehold
99 GBP2024-04-01 ~ 2025-03-31
Computers, Owned/Freehold
402 GBP2024-04-01 ~ 2025-03-31
Owned/Freehold
9,386 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
62,540 GBP2025-03-31
Office equipment
99 GBP2025-03-31
Computers
1,303 GBP2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
63,942 GBP2025-03-31
Property, Plant & Equipment
Plant and equipment
45,342 GBP2025-03-31
Office equipment
1,109 GBP2025-03-31
Computers
1,483 GBP2025-03-31
1,885 GBP2024-03-31
Other Debtors
Current
4,202 GBP2025-03-31
9,815 GBP2024-03-31
Prepayments/Accrued Income
Current
2,534 GBP2025-03-31
Amount of corporation tax that is recoverable
Current
140,498 GBP2025-03-31
29,206 GBP2024-03-31
Trade Creditors/Trade Payables
Current
940 GBP2025-03-31
750 GBP2024-03-31
Taxation/Social Security Payable
Current
7,153 GBP2024-03-31
Other Creditors
Current
2,829 GBP2025-03-31
2,709 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
46,305 GBP2025-03-31
5,000 GBP2024-03-31
Creditors
Current
50,074 GBP2025-03-31
15,612 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
368,072 shares2025-03-31
368,072 shares2024-03-31
Par Value of Share
Class 1 ordinary share
0.00012024-04-01 ~ 2025-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
1,809 GBP2025-03-31
983 GBP2024-03-31
  • RENOVOS BIOLOGICS LIMITED
    Info
    Registered number 10685524
    icon of address2 Venture Road Southampton Science Park, Chilworth, Southampton SO16 7NP
    PRIVATE LIMITED COMPANY incorporated on 2017-03-22 (8 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.